ASHLEY ARROWOOD: Open Payments
NPI 1437807583 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,791 in 124 payments from 22 companies in 2025. Trend: 2023 $754 · 2024 $2,038 · 2025 $2,791
Food & beverage: $2,776Education: $15
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $396 |
| AstraZeneca Pharmaceuticals LP | 5 | $314 |
| Travere Therapeutics, Inc. | 29 | $298 |
| Calliditas Therapeutics US Inc. | 11 | $249 |
| AKEBIA THERAPEUTICS INC | 5 | $188 |
| ANI Pharmaceuticals, Inc. | 7 | $169 |
| Vifor Pharma, Inc. | 10 | $142 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $126 |
| OPKO Pharmaceuticals, LLC | 6 | $113 |
Products named: LOKELMA, TARPEYO, KRYSTEXXA, Vafseo, TAVNEOS, PURIFIED CORTROPHIN GEL, Veltassa, Kerendia.
Industry payments across MO — which companies pay providers there.
